Biotech Values

[gofishmarko]

Re: Is a Shotgun Better Than a Silver Bullet?

>>>> The FDA has long held botanical drugs to the same standard as other therapies: Companies applying for regulatory approval had to find the part that works and prove it. <<<<

Except for drugs composed of two or more isomers , some of which may be more active , inactive , or counter-active. In this case , you get approval for the mix first , use up your years of patent protection , then come back later for approval of a purified isomer drug and more years of market exclusivity.

I'm glad to see the FDA opening their eyes to other ways of doing things , but I have my doubts about how rational they will be implementing this new policy , given their history.

If you can now test combos of a hundred compounds in a botanical , it should be no problem testing two or more novel compounds versus hepatitis c.

In a rational world , that is.